<DOC>
	<DOCNO>NCT02775058</DOCNO>
	<brief_summary>The device investigation SYNERGOSS , CE ( European Community CE ) mark device . Synergoss granulate bone graft intend use dental application . It compose ceramic composite Hydroxihapatite Tricalciumphosphate granule , coat dedicate collagen coating ( porcine origin ) , obtain mean collagen crosslinking ceramic granule surface . The purpose study confirm foreseen efficacy tolerability SYNERGOSS , synthetic dental graft coat collagen . For observational study , enroll patient already receive surgical intervention sinus augmentation/ socket preservation mean SYNERGOSS maintain regenerate bone installation endosseous titanium implant support fix prosthesis . Patients enrol receive surgery installation endosseous titanium implant , 24 week first surgery implant SYNERGOSS . The primary hypothesis demonstrate SYNERGOSS consistently obtain foreseen clinical benefit declare Technical File . The secondary hypothesis demonstrate SYNERGOSS side effect risk match declare Technical File . The study design - National - Monocentric - Prospective : participant identify follow forward time . - Observational : participant recently receive grafting SYNERGIES part normal foreseen clinical procedure enrol study receive surgery titanium implant placement observe time , substantial intervention foreseen clinical treatment</brief_summary>
	<brief_title>CP009 SYNERGOSS PXX Observational</brief_title>
	<detailed_description />
	<mesh_term>Mouth , Edentulous</mesh_term>
	<criteria>• Received past 1624 week bone graft sinus lift socket preservation ID Capable give valid informed consent ASA 1 , ASA 2 agree return followup visit 2 year • Uncontrolled Diabetes Patients psychiatric disease Neoplasic , immunodepressive , renal liver major illness Local radiotherapy Major bruxism major difference maxilla mandubilar area Drug alcohol abuse Major bone metabolism disorder Heavy smoker ( 10/day ) bisphosphonate treatment major ostheoporosys bone neoplasia Pregnant woman Sinus illnesses Contraindications implant support prosthesis Patients ASA 3 , ASA 4 , ASA5 Surgical intervention contraindication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>